Roche edges lower as growth metrics diverge, quality score holds
Roche slipped 0.83% to $60.57 on Wednesday, a modest decline that left the stock near the lower end of its 52-week range. The company's Alpha Score of 49.2 reflects a mixed fundamental picture. Earnings per share grew 30.5% year over year, well ahead of the 3.0% revenue expansion, suggesting margin improvement drove the bottom line. Net margin came in at 22.6%. The quality sub-score of 70.6 is the strongest pillar, while momentum at 51.3 and value at 42.8 lag. The P/E of 25.98 is elevated relative to the single-digit revenue growth rate. Investors will watch for any update on Roche's pipeline or cost initiatives when the company next reports.